Full Press Release Details
regeneron to highlight progress across its metabolic disease ophthalmology and rare disease pipelines at ada and endo.
REGN
regeneron to highlight progress across its metabolic disease ophthalmology and rare disease pipelines at ada and endo
Key Takeaway: regeneron to highlight progress across its metabolic disease ophthalmology and rare disease pipelines at ada and endo